News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Richard A. Young, Syros Pharmaceuticals Scientific Founder, To Open American Association for Cancer Research Annual Meeting 2014 With Address Highlighting His Pioneering Gene Control Research


4/2/2014 7:40:46 AM

free biotech news Get the latest biotech news where you want it. Sign up for the free GenePool newsletter today!

Syros Pharmaceuticals, a life sciences company harnessing breakthroughs in gene control to revolutionize the treatment of cancer and other diseases, announced today that one of its scientific co-founders, Richard A. Young, Ph.D., will give the opening address at the American Association for Cancer Research (AACR) Annual Meeting 2014. In his lecture, entitled “Transcriptional and Epigenetic Control of Tumor Cells,” Dr. Young will discuss new insights into the gene control mechanisms that contribute to tumor pathogenesis and opportunities for transcriptional therapeutics. The presentation is scheduled for AACR’s first plenary session: “Harnessing Breakthroughs, Targeting Cures” on April 6 at 9:15 a.m. PT in Hall F-G at the San Diego Convention Center.

Help employers find you! Check out all the jobs and post your resume.

Read at BioSpace.com


comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES